Jacob Pe'er Selected Research

Jacob Pe'er Research Topics

Disease

26	Neoplasms (Cancer) 03/2022 - 06/2002
24	Uveal melanoma 03/2022 - 06/2002
21	Melanoma (Melanoma, Malignant) 04/2016 - 02/2002
18	Neoplasm Metastasis (Metastasis) 03/2022 - 02/2004
6	Lymphoma (Lymphomas) 01/2022 - 09/2002
5	Retinoblastoma (Glioblastoma, Retinal) 01/2018 - 09/2007
4	Inflammation (Inflammations) 03/2022 - 06/2002
3	Melanosis (Freckles) 12/2010 - 02/2005
2	Intraocular Lymphoma 01/2021 - 07/2007
2	Retinal Detachment (Retinal Detachments) 04/2014 - 12/2013
2	Macular Degeneration (Age-Related Maculopathy) 06/2012 - 04/2010
2	Nevus (Nevi) 12/2010 - 06/2002
1	Atrophy 04/2021
1	Vasculitis (Vasculitides) 10/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2018
1	Carcinoma (Carcinomatosis) 10/2018
1	Infections 05/2018
1	Hypoxia (Hypoxemia) 05/2018
1	Retinal Diseases 01/2018
1	Norrie disease 12/2014
1	Mycoses (Diseases, Fungus) 06/2012
1	Cataract (Cataracts) 06/2012
1	Posterior Uveitis 04/2010
1	Retinitis 04/2010
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2010
1	Limbal Stem Cell Deficiency 03/2010
1	Glaucoma 02/2008
1	Colonic Neoplasms (Colon Cancer) 10/2007
1	Myeloid Leukemia (Leukemia, Myelocytic) 09/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2007

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2002
6	Biomarkers (Surrogate Marker)IBA 03/2022 - 07/2007
5	OsteopontinIBA 03/2022 - 03/2006
5	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2010 - 03/2002
5	Laminin (Merosin)IBA 07/2007 - 08/2002
4	ParaffinIBA 03/2007 - 12/2002
4	Formaldehyde (Formol)FDA Link 03/2007 - 12/2002
3	Retinaldehyde (Retinal)IBA 04/2021 - 06/2012
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 09/2002
3	Tumor Biomarkers (Tumor Markers)IBA 04/2011 - 01/2011
3	Messenger RNA (mRNA)IBA 04/2010 - 06/2002
3	RutheniumIBA 09/2005 - 06/2002
2	CytokinesIBA 09/2020 - 06/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2011
2	EnzymesIBA 01/2013 - 06/2005
2	tissue polypeptide specific antigenIBA 01/2011 - 01/2011
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2011 - 02/2004
2	Transcription Factors (Transcription Factor)IBA 04/2010 - 11/2007
2	HydrogelsIBA 03/2008 - 07/2007
2	sodium bisulfite FDA Link 02/2008 - 10/2007
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2008 - 10/2007
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 03/2022
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2018
1	MucinsIBA 10/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2018
1	AutoantibodiesIBA 10/2018
1	Dacarbazine (DIC)FDA LinkGeneric 05/2018
1	Alkylating AgentsIBA 05/2018
1	Caspase 3 (Caspase-3)IBA 05/2018
1	fotemustine (Muphoran)IBA 05/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 04/2016
1	CateninsIBA 12/2014
1	Anti-Allergic Agents (Antiallergic Agents)IBA 05/2014
1	ImmunosorbentsIBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013
1	Iodine-125IBA 01/2012
1	IsotopesIBA 01/2012
1	Ruthenium-106IBA 01/2012
1	Cobalt-60IBA 01/2012
1	Cell Adhesion MoleculesIBA 12/2011
1	Cell Adhesion Molecule-1IBA 12/2011
1	CEACAM1 ProteinIBA 12/2011
1	Carcinoembryonic AntigenIBA 12/2011
1	Codon (Codons)IBA 12/2010
1	Interferon-alpha2bIBA 05/2010
1	Fluorouracil (Carac)FDA LinkGeneric 05/2010
1	NF-kappa B (NF-kB)IBA 04/2010
1	4(2'- aminoethyl)amino- 1,8- dimethylimidazo(1,2- a)quinoxalineIBA 04/2010
1	Pharmaceutical PreparationsIBA 04/2010
1	Inhibitor of Apoptosis ProteinsIBA 10/2008
1	Carboplatin (JM8)FDA LinkGeneric 03/2008
1	Death-Associated Protein KinasesIBA 02/2008
1	OligonucleotidesIBA 11/2007
1	Keratin-18 (Keratin 18)IBA 10/2007
1	Etoposide (VP 16)FDA LinkGeneric 09/2007
1	Podophyllotoxin (Condylox)FDA LinkGeneric 09/2007
1	S100 Calcium Binding Protein beta SubunitIBA 07/2007
1	SuspensionsIBA 07/2007

Therapy/Procedure

9	Therapeutics 05/2018 - 11/2004
9	Brachytherapy 04/2014 - 06/2002
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2002
6	Lasers (Laser) 06/2012 - 03/2007
4	Aftercare (After-Treatment) 01/2013 - 03/2006
1	Vitrectomy 12/2013
1	Electrodes (Electrode) 01/2013
1	Induced Hyperthermia (Thermotherapy) 01/2012
1	Iridectomy 10/2011